ZL103_00_003e_WL Guidance document Authorisation of individual teas, cough and throat lozenges and pastilles in the notification procedure HMV4

Information

Type

Guidance

Regulated products

Medical Devices

Published

January 29, 2019

Last updated

January 29, 2019

Description

This document provides guidance on the authorization process for teas, cough and throat lozenges, and pastilles in the HMV4 notification procedure.

Organization

Country / Region

Switzerland

License

Other (Non-Commercial)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed